Ask Your Colleagues About:

Treatment Strategies
 

CCC-Slp Dionysios Tafiadis

Posted: Dec 8, 2005

QUESTION:

What are the chacnce for a patient to show lypodystrophy or lypoatrophy with the combination of Zidovudine/Lamivudine (Combivir) and Storcrine? Thank u a priori!!


  

RESPONSE FROM:   

    Fat wasting would be unlikely but possible. AZT has beenassociated with fat loss. Fat gain is being seen with all therapies. However, Sustiva would be unlikely to produce large amounts of fatt accumulation of the belly.

    Over all, it will probably be okay.

    DW




Terms of Use: Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body PRO, Body Health Resources Corporation or any sponsor of this forum.

Visitors submitting questions remain solely responsible for the content of their messages. Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care.

powered by ExpertViewpoint